EUVIMEDEUVIMED entdecken
Fallbericht

Efficacy of low-dose naltrexone in an adolescent with difficult to treat juvenile fibromyalgia – a case report

Anna Maria Łotowska-Ręczmień

BÓL · 14.01.2026 · 26 (4) · 42-46

DOI: 10.5604/01.3001.0055.6212 ↗

Kurz gefasst

Fallbericht in der Zeitschrift BÓL, erschienen am 14.01.2026. Verfasst von Anna Maria Łotowska-Ręczmień. Die Arbeit nennt 16 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Juvenile primary fibromyalgia syndrome (JPFS) is a chronic pain condition with a multifactorial etiology involving central sensitization and psychosocial factors. Treatment of JPFS remains a significant clinical challenge, and standard pharmacological and non-pharmacological therapies often provide limited benefit. In recent years, low-dose naltrexone (LDN) has gained increasing interest due to its potential analgesic effects through modulation of microglial activation and reduction of neuroinflammation.We present the case of an adolescent with JPFS, comorbid Asperger’s syndrome, and mood disorder, who showed no improvement despite years of multidisciplinary treatment. LDN therapy was initiated using a gradual titration protocol: 0.5 mg daily for 10 days, then 1 mg for 10 days, followed by 1.5 mg daily. After 35 days, the patient reported significant improvement, including pain reduction (NRS 3), better sleep quality and concentration, and successful reintegration into regular school attendance.The treatment was well tolerated, with no adverse effects observed. The patient described LDN therapy as the most effective among previously used interventions.LDN may represent a promising therapeutic option for adolescents with treatment-resistant JPFS. Further controlled clinical studies in pediatric populations are warranted to confirm its efficacy, safety, and optimal dosing regimen.

Zitieren

APA

Łotowska-Ręczmień, A. M. (2026). Efficacy of low-dose naltrexone in an adolescent with difficult to treat juvenile fibromyalgia – a case report. BÓL, 26(4), 42-46. https://doi.org/10.5604/01.3001.0055.6212

Vancouver

Łotowska-Ręczmień AM. Efficacy of low-dose naltrexone in an adolescent with difficult to treat juvenile fibromyalgia – a case report. BÓL. 2026;26(4):42-46. doi:10.5604/01.3001.0055.6212

BibTeX
@article{otowskaRczmie2026,
  author = {Łotowska-Ręczmień, Anna Maria},
  title = {Efficacy of low-dose naltrexone in an adolescent with difficult to treat juvenile fibromyalgia – a case report},
  journal = {BÓL},
  year = {2026},
  volume = {26},
  number = {4},
  pages = {42--46},
  doi = {10.5604/01.3001.0055.6212}
}
Kostenlos starten →